NAVADHI Market Research
Published on NAVADHI Market Research (https://www.navadhi.com)

Home > Global Automatic Plate Washer Market Strategic Research Report 2026-2031

Global Automatic Plate Washer Market Strategic Research Report 2026-2031

Global Automatic Plate Washer Market Strategic Research Report 2026-2031
Publication ID: 
NAV1026074
Publication Date: 
November 18, 2026
Pages: 
244
Countries: 
Global [1]
Please choose the suitable license type from above. More details are at given under tab "Report License Types" below.

The global automatic plate washer market is valued at US$179.4 million in 2025 and is forecast to reach US$247.2 million by 2031, a compound annual growth rate (CAGR) of 5.5% over 2025-2031. The report covers standalone, programmable laboratory instruments that dispense and aspirate wash solution in microplates between assay steps: strip washers, 96-well and 384-well capable units, deep-well washers and magnetic-bead and cell-wash capable systems sold new to end-user laboratories. Manual and semi-automatic manifolds, consumables, spare parts, service contracts, plate readers, liquid handlers and integrated ELISA processors where the washer is not priced separately are excluded.

The report segments the market by type and application across five regions and 27 country-level lines. General-purpose plate washers account for 67.0% of 2025 value (US$120.3 million, 4.4% CAGR) and special-purpose plate washers for 33.0% (US$59.1 million, 7.5% CAGR). Biopharma and Biotech is the largest application at 36.5% of 2025 value (6.4% CAGR), followed by Hospitals and Clinical Labs at 29.4% (5.5% CAGR); CROs and CDMOs is the fastest growing at 6.7% CAGR. North America holds 32.3% of 2025 value, Asia Pacific 30.4% and is the fastest growing region at 6.9% CAGR. Values are Navadhi Market Research estimates built from observed list prices, tender prices and installed-base anchors; no company discloses plate washer revenue.

Scope of the Global Automatic Plate Washer Market Strategic Research Report

This report covers market value (US$ million) for 2022-2031, with 2025 as the base year and 2026-2031 as the forecast period. It analyses two instrument types, four applications, five regions and 27 country-level lines, and includes profiles of 17 companies, competitive landscape, Porter's Five Forces, PESTLE, SWOT and future trends. Unit volumes are discussed as an installed-base analysis (Section 2.4) and are not published as a series.

Segment by Type

  • General-purpose Plate Washers
  • Special-purpose Plate Washers

Segment by Application

  • Hospitals and Clinical Labs
  • Biopharma and Biotech
  • CROs and CDMOs
  • Others

Who Can Use This Report?

  • Plate washer, ELISA automation and laboratory instrument makers benchmarking price tiers and segments
  • Distributors and tender suppliers sizing hospital, biopharma and CRO demand by region and country
  • Biopharma, CRO and clinical laboratory procurement teams comparing instrument classes and price ranges
  • Investors and consultants who need a sourced, estimate-labelled view of a market with no disclosed segment revenue

1. Executive Summary
    1.1 Market Definition and Scope
    1.2 Market Size and Growth Trajectory
    1.3 Principal Growth Drivers
    1.4 Segment and Regional Highlights
    1.5 Competitive Structure and Key Corporate Developments
    1.6 Principal Risks
    1.7 Closing Outlook
2. Industry Overview & Forecast
    2.1 Market Definition and Scope
    2.2 Market Size and Historical Performance
    2.3 Forecast and Growth Logic
    2.4 Volume and Installed-Base Analysis
    2.5 Value Chain and Pricing Dynamics
3. Market Segmentation by Type
    3.1 Overview of the Type Dimension
    3.1.1 General-purpose Plate Washers
    3.1.2 Special-purpose Plate Washers
    3.1.3 Comparative Mix Shift and Structural Implications
4. Market Segmentation by Application
    4.1 Overview of Application Structure
    4.1.1 Hospitals and Clinical Labs
    4.1.1.1 Segment Characteristics and Market Scale
    4.1.1.2 Instrument Profile and Procurement Patterns
    4.1.1.3 Buyer Behaviour, Replacement Cycles, and Risks
    4.1.2 Biopharma and Biotech
    4.1.2.1 Segment Characteristics and Market Scale
    4.1.2.2 Instrument Profile and Procurement Patterns
    4.1.2.3 Buyer Behaviour, Replacement Cycles, and Risks
    4.1.3 CROs and CDMOs
    4.1.3.1 Segment Characteristics and Market Scale
    4.1.3.2 Instrument Profile and Procurement Patterns
    4.1.3.3 Buyer Behaviour, Replacement Cycles, and Risks
    4.1.4 Others
    4.1.4.1 Segment Characteristics and Market Scale
    4.1.4.2 Instrument Profile and Procurement Patterns
    4.1.4.3 Buyer Behaviour, Replacement Cycles, and Risks
    4.2 Comparative Segment Analysis
5. Regional Market Forecast
    5.1 North America
    5.1.1 Regional Overview
    5.1.2 Key Growth Drivers
    5.1.3 Regulatory & Infrastructure Landscape
    5.1.4 Country-Level Analysis
    5.1.5 Market Forecast 2025–2031
    5.2 Europe
    5.2.1 Regional Overview
    5.2.2 Key Growth Drivers
    5.2.3 Regulatory & Infrastructure Landscape
    5.2.4 Country-Level Analysis
    5.2.5 Market Forecast 2025–2031
    5.3 Asia Pacific
    5.3.1 Regional Overview
    5.3.2 Key Growth Drivers
    5.3.3 Regulatory & Infrastructure Landscape
    5.3.4 Country-Level Analysis
    5.3.5 Market Forecast 2025–2031
    5.4 Latin America
    5.4.1 Regional Overview
    5.4.2 Key Growth Drivers
    5.4.3 Regulatory & Infrastructure Landscape
    5.4.4 Country-Level Analysis
    5.4.5 Market Forecast 2025–2031
    5.5 Middle East and Africa
    5.5.1 Regional Overview
    5.5.2 Key Growth Drivers
    5.5.3 Regulatory & Infrastructure Landscape
    5.5.4 Country-Level Analysis
    5.5.5 Market Forecast 2025–2031
6. Country-Level Market Forecast
    6.1 North America
    6.1.1 United States
    6.1.2 Canada
    6.1.3 Mexico
    6.2 Europe
    6.2.1 Germany
    6.2.2 United Kingdom
    6.2.3 France
    6.2.4 Italy
    6.2.5 Spain
    6.2.6 Rest of Europe
    6.3 Asia Pacific
    6.3.1 China
    6.3.2 Japan
    6.3.3 India
    6.3.4 South Korea
    6.3.5 Australia
    6.3.6 Southeast Asia
    6.3.7 Rest of Asia Pacific
    6.4 Latin America
    6.4.1 Brazil
    6.4.2 Argentina
    6.4.3 Colombia
    6.4.4 Chile
    6.4.5 Rest of Latin America
    6.5 Middle East and Africa
    6.5.1 GCC Countries
    6.5.2 Turkey
    6.5.3 Israel
    6.5.4 South Africa
    6.5.5 Egypt
    6.5.6 Rest of Middle East and Africa
7. Growth Drivers & Inhibitors
    7.1 Strategic Context
    7.2 Market Growth Drivers
    7.2.1 Entrenchment of Plate-Based Immunoassay and ELISA Workflows in Clinical Diagnostics
    7.2.2 Accelerating Biopharma Bioanalysis, CRO, and CDMO Testing Requirements
    7.2.3 Demand for Automated Washing to Reduce Assay Variability and Manual Labour
    7.2.4 Expansion of Laboratory Capacity in Asia Pacific and Other Emerging Markets
    7.2.5 Persistent Replacement Cycle Demand from an Established Installed Base
    7.2.6 Growing Demand for Workflow Consistency Across Multi-Site Laboratory Networks
    7.3 Market Restraints
    7.3.1 Price Pressure from Low-Cost Asian Instrument Manufacturers in the General-Purpose Segment
    7.3.2 Integration of Washers into Fully Automated ELISA and Immunoassay Systems
    7.3.3 Extended Instrument Lifecycle Constraining Replacement Velocity
    7.3.4 Constrained Academic and Biotech Funding in Cyclical Years
    7.3.5 Absence of Transparent Market Data Limiting Strategic Pricing and Investment
    7.4 Impact Assessment Summary
    7.5 Integrated Assessment
8. Key Company Profiles
    8.1 Thermo Fisher Scientific

    8.1.1 Company Overview
    8.1.2 Key Products & Segments
    8.1.3 Financial Performance (2023–2025)
    8.1.4 Business Strategy
    8.1.5 SWOT Analysis
    8.1.6 Strategic Implications (2025–2031)
    8.2 Agilent Technologies
    8.2.1 Company Overview
    8.2.2 Key Products & Segments
    8.2.3 Financial Performance (2023–2025)
    8.2.4 Business Strategy
    8.2.5 SWOT Analysis
    8.2.6 Strategic Implications (2025–2031)
    8.3 Bio-Rad Laboratories
    8.3.1 Company Overview
    8.3.2 Key Products & Segments
    8.3.3 Financial Performance (2023–2025)
    8.3.4 Business Strategy
    8.3.5 SWOT Analysis
    8.3.6 Strategic Implications (2025–2031)
    8.4 Tecan
    8.4.1 Company Overview
    8.4.2 Key Products & Segments
    8.4.3 Financial Performance (2023–2025)
    8.4.4 Business Strategy
    8.4.5 SWOT Analysis
    8.4.6 Strategic Implications (2025–2031)
    8.5 Biobase
    8.5.1 Company Overview
    8.5.2 Key Products & Segments
    8.5.3 Financial Performance (2023–2025)
    8.5.4 Business Strategy
    8.5.5 SWOT Analysis
    8.5.6 Strategic Implications (2025–2031)
    8.6 Molecular Devices
    8.6.1 Company Overview
    8.6.2 Key Products & Segments
    8.6.3 Financial Performance (2023–2025)
    8.6.4 Business Strategy
    8.6.5 SWOT Analysis
    8.6.6 Strategic Implications (2025–2031)
    8.7 Berthold Technologies
    8.7.1 Company Overview
    8.7.2 Key Products & Segments
    8.7.3 Financial Performance (2023–2025)
    8.7.4 Business Strategy
    8.7.5 SWOT Analysis
    8.7.6 Strategic Implications (2025–2031)
    8.8 Dynex Technologies
    8.8.1 Company Overview
    8.8.2 Key Products & Segments
    8.8.3 Financial Performance (2023–2025)
    8.8.4 Business Strategy
    8.8.5 SWOT Analysis
    8.8.6 Strategic Implications (2025–2031)
    8.9 CYTENA
    8.9.1 Company Overview
    8.9.2 Key Products & Segments
    8.9.3 Financial Performance (2023–2025)
    8.9.4 Business Strategy
    8.9.5 SWOT Analysis
    8.9.6 Strategic Implications (2025–2031)
    8.10 Awareness Technology
    8.10.1 Company Overview
    8.10.2 Key Products & Segments
    8.10.3 Financial Performance (2023–2025)
    8.10.4 Business Strategy
    8.10.5 SWOT Analysis
    8.10.6 Strategic Implications (2025–2031)
    8.11 CAPP (AHN Biotechnologie)
    8.11.1 Company Overview
    8.11.2 Key Products & Segments
    8.11.3 Financial Performance (2023–2025)
    8.11.4 Business Strategy
    8.11.5 SWOT Analysis
    8.11.6 Strategic Implications (2025–2031)
    8.12 Biosan
    8.12.1 Company Overview
    8.12.2 Key Products & Segments
    8.12.3 Financial Performance (2023–2025)
    8.12.4 Business Strategy
    8.12.5 SWOT Analysis
    8.12.6 Strategic Implications (2025–2031)
    8.13 Mindray
    8.13.1 Company Overview
    8.13.2 Key Products & Segments
    8.13.3 Financial Performance (2023–2025)
    8.13.4 Business Strategy
    8.13.5 SWOT Analysis
    8.13.6 Strategic Implications (2025–2031)
    8.14 Autobio
    8.14.1 Company Overview
    8.14.2 Key Products & Segments
    8.14.3 Financial Performance (2023–2025)
    8.14.4 Business Strategy
    8.14.5 SWOT Analysis
    8.14.6 Strategic Implications (2025–2031)
    8.15 KHB
    8.15.1 Company Overview
    8.15.2 Key Products & Segments
    8.15.3 Financial Performance (2023–2025)
    8.15.4 Business Strategy
    8.15.5 SWOT Analysis
    8.15.6 Strategic Implications (2025–2031)
    8.16 URIT
    8.16.1 Company Overview
    8.16.2 Key Products & Segments
    8.16.3 Financial Performance (2023–2025)
    8.16.4 Business Strategy
    8.16.5 SWOT Analysis
    8.16.6 Strategic Implications (2025–2031)
    8.17 Rayto
    8.17.1 Company Overview
    8.17.2 Key Products & Segments
    8.17.3 Financial Performance (2023–2025)
    8.17.4 Business Strategy
    8.17.5 SWOT Analysis
    8.17.6 Strategic Implications (2025–2031)
9. Competitive Landscape
    9.1 Competitive Landscape Overview
    9.1.1 Profiled Company Reference Table
    9.1.2 Why Market Share Cannot Be Measured
    9.1.3 Competitive Intensity and Strategic Differentiation
    9.2 Competitive Intensity Assessment
    9.2.1 Structural Grouping of Participants
    9.2.2 Capacity Versus Demand Dynamics
    9.2.3 Pricing Environment
    9.2.4 Barriers to Entry and Exit
    9.3 Key Player Strategies & Positioning
    9.3.1 Strategic Group Map
    9.3.2 Platform Integrators: Scale as a Differentiator
    9.3.3 Specialist Automation: Tecan's Niche Depth
    9.3.4 Chinese IVD Platforms: Volume, Price, and Domestic Scale
    9.3.5 Low-Cost Volume Suppliers: Biobase and Rayto
    9.3.6 Emerging and Niche Entrants
    9.3.7 R&D and Technology Investment Trends
    9.3.8 M&A and Partnership Activity (2022–Present)
    9.4 Competitive Dynamics & Strategic Outlook
    9.4.1 Incumbent Landscape Without Disclosed Market Shares
    9.4.2 Emerging Competitive Threats
    9.4.3 Consolidation vs. Fragmentation Outlook
    9.4.4 Competitive Response Matrix
    9.4.5 Strategic Recommendations for 2026–2031
10. Porter's Five Forces Analysis
    10.1 Threat of New Entrants
    10.2 Bargaining Power of Buyers
    10.3 Bargaining Power of Suppliers
    10.4 Threat of Substitutes
    10.5 Competitive Rivalry
11. PESTLE Analysis
    11.1 Overview
    11.2 Political
    11.3 Economic
    11.4 Social
    11.5 Technological
    11.6 Legal and Regulatory
    11.7 Environmental
    11.8 PESTLE Summary Table
12. SWOT Analysis
    12.1.1 Detailed Analysis
    12.1.1.1 Strengths
    12.1.1.2 Weaknesses
    12.1.1.3 Opportunities
    12.1.1.4 Threats
    12.1.2 Strategic Implications and Priority Actions
13. Future Trends & Outlook
    13.1 Overview
    13.2 Accelerating Shift Toward Special-Purpose Plate Washers
    13.3 Asia Pacific's Rising Share and the Centre of Gravity Shift
    13.4 Persistent Price Duality and the Commoditisation of General-Purpose Instruments
    13.5 CRO and CDMO Sector Expansion as a Structural Demand Driver
    13.6 Hospital and Clinical Lab Modernisation as a Volume Driver in Emerging Markets
    13.7 Product Innovation in Multifunction and High-Density Plate Formats
    13.8 Scenario Divergence and the Risk of Downside Growth Compression
    13.9 Summary of Future Trends
    13.10 Forward Outlook

List of Exhibits
Exhibit 2.1: Forecast of Global Market YoY Growth Rate & CAGR Summary (in %)
Exhibit 2.2: Forecast of Global Market (in USD Mn)
Exhibit 2.3: Forecast of North America (in USD Mn)
Exhibit 2.4: Forecast of Europe (in USD Mn)
Exhibit 2.5: Forecast of Asia Pacific (in USD Mn)
Exhibit 2.6: Forecast of Latin America (in USD Mn)
Exhibit 2.7: Forecast of Middle East and Africa (in USD Mn)
Exhibit 3.8: Forecast of General-purpose Plate Washers (in USD Mn)
Exhibit 3.9: Forecast of Special-purpose Plate Washers (in USD Mn)
Exhibit 4.10: Forecast of Hospitals and Clinical Labs (in USD Mn)
Exhibit 4.11: Forecast of Biopharma and Biotech (in USD Mn)
Exhibit 4.12: Forecast of CROs and CDMOs (in USD Mn)
Exhibit 4.13: Forecast of Others (in USD Mn)
Exhibit 6.14: Forecast of North America (in USD Mn)
Exhibit 6.15: Forecast of United States (in USD Mn)
Exhibit 6.16: Forecast of Canada (in USD Mn)
Exhibit 6.17: Forecast of Mexico (in USD Mn)
Exhibit 6.18: Forecast of Europe (in USD Mn)
Exhibit 6.19: Forecast of Germany (in USD Mn)
Exhibit 6.20: Forecast of United Kingdom (in USD Mn)
Exhibit 6.21: Forecast of France (in USD Mn)
Exhibit 6.22: Forecast of Italy (in USD Mn)
Exhibit 6.23: Forecast of Spain (in USD Mn)
Exhibit 6.24: Forecast of Rest of Europe (in USD Mn)
Exhibit 6.25: Forecast of Asia Pacific (in USD Mn)
Exhibit 6.26: Forecast of China (in USD Mn)
Exhibit 6.27: Forecast of Japan (in USD Mn)
Exhibit 6.28: Forecast of India (in USD Mn)
Exhibit 6.29: Forecast of South Korea (in USD Mn)
Exhibit 6.30: Forecast of Australia (in USD Mn)
Exhibit 6.31: Forecast of Southeast Asia (in USD Mn)
Exhibit 6.32: Forecast of Rest of Asia Pacific (in USD Mn)
Exhibit 6.33: Forecast of Latin America (in USD Mn)
Exhibit 6.34: Forecast of Brazil (in USD Mn)
Exhibit 6.35: Forecast of Argentina (in USD Mn)
Exhibit 6.36: Forecast of Colombia (in USD Mn)
Exhibit 6.37: Forecast of Chile (in USD Mn)
Exhibit 6.38: Forecast of Rest of Latin America (in USD Mn)
Exhibit 6.39: Forecast of Middle East and Africa (in USD Mn)
Exhibit 6.40: Forecast of GCC Countries (in USD Mn)
Exhibit 6.41: Forecast of Turkey (in USD Mn)
Exhibit 6.42: Forecast of Israel (in USD Mn)
Exhibit 6.43: Forecast of South Africa (in USD Mn)
Exhibit 6.44: Forecast of Egypt (in USD Mn)
Exhibit 6.45: Forecast of Rest of Middle East and Africa (in USD Mn)

  1. Thermo Fisher Scientific
  2. Agilent Technologies
  3. Bio-Rad Laboratories
  4. Tecan
  5. Biobase
  6. Molecular Devices
  7. Berthold Technologies
  8. Dynex Technologies
  9. CYTENA
  10. Awareness Technology
  11. CAPP (AHN Biotechnologie)
  12. Biosan
  13. Mindray
  14. Autobio
  15. KHB
  16. URIT
  17. Rayto

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Enterprise license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Enterprise license fee.

 

Enterprise License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

About Us

NAVADHI is a market research company that helps global firms differentiate themselves, break market entry barriers, track their investments, develop business strategies and plan for future by providing actionable market research intelligence that helps them succeed.

Infomation

  • About Us
  • Publications
  • FAQs
  • Privacy Policy
  • Terms & Conditions
  • Careers
  • Press Releases
  • Contact

Source URL:https://www.navadhi.com/publications/global-automatic-plate-washer-market-strategic-research-report-2026-2031

Links
[1] https://www.navadhi.com/countries/global